Changes in incidence and survival of ewing sarcoma patients over the past 3 decades: Surveillance epidemiology and end results data

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 6, 2008, Pages 425-430

  Esiashvili, Natia ^a   Goodman, Michael ^b   Marcus, Robert B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Ewing sarcoma; SEER; Survival

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CHILD; DISTANT METASTASIS; EWING SARCOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL TIME; BONE TUMOR; INCIDENCE; INFANT; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; SURVIVAL; SURVIVAL RATE;

ADOLESCENT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; SARCOMA, EWING'S; SEER PROGRAM; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 47549083691     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31816e22f3     Document Type: Article

References (28)

1. Gurney JG, Swensen AR, Bulterys M. Malignant bone tumors. In: Ries LAG, Smith MA, Gurney JG, et al, eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Institutes of Health; 1999:99-110.
2. Stiller CA, Passmore SJ, Kroll ME, et al. Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994. Br J Cancer. 2006;94:22-29.
3. Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol. 2000;18:3108-3114.
4. Dunst J, Jurgens H, Sauer R, et al. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys. 1995;32:919-930.
5. Fraumeni JF Jr, Glass AG. Rarity of Ewing's sarcoma among U.S. Negro children. Lancet. 1970;1:366-367.
6. Li FP, Tu JT, Liu FS, et al. Rarity of Ewing's sarcoma in China. Lancet. 1980;1:1255.
7. Cangir A, Vietti T, Gehan EA, et al. Ewing's sarcoma metastatic at diagnosis: results and comparisons of two intergroup Ewing's sarcoma studies. Cancer. 1990;66:887-893.
8. Burdach S, Jurgens H, Peters C, et al. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol. 1993;11:1482-1488.
9. Sandoval C, Meyer WH, Parham DM, et al. Outcome in 43 children presenting with metastatic Ewing sarcoma: the St. Jude Children's Research Hospital experience, 1962-1992. Med Pediatr Oncol. 1996;26:180-185.
10. Paulussen M, Ahrens S, Burdach S, et al. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies - European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol. 1998;9:275-281.
11. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348: 694-701.
12. Meyers PA, Krailo MD, Ladanyi M, et al. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol. 2001;19:2812-2820.
13. Bernstein ML, Devidas M, Lafreniere D, et al. Pediatric Oncology Group; Children's Cancer Group Phase II Study 9457; Children's Oncology Group. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457 - a report from the Children's Oncology Group. J Clin Oncol. 2006;24:152-159.
14. Nesbit ME Jr, Gehan EA, Burgert EO Jr, et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol. 1990;8:1664-1674.
15. Bacci G, Longhi A, Ferrari S, et al. Prognostic factors in nonmetastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998. Acta Oncol. 2006;45: 469-475.
16. Bacci G, Longhi A, Briccoli A, et al. The role of surgical margins in treatment of Ewing's sarcoma family tumors: experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 2006;65:766-772.
17. Paulussen M, Ahrens S, Dunst J, et al. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol. 2001;19:1818-1829.
18. Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999;8:1117-1121.
19. NCI (National Cancer Institute), 2006, About SEER. NIH Publication No. 05-4772. Available at: http://seer.cancer.gov/about/ (accessed October 21, 2007).
20. Percy C, Van Holten V, Muir C, et al. International Classification of Diseases for Oncology. 2nd ed. Geneva (Switzerland): World Health Organization; 1992.
21. SEER Extent of Disease 1988, Codes and Coding Instructions (3rd ed, 1998).
22. Jenkin RD. Ewing's sarcoma a study of treatment methods. Clin Radiol. 1966;17:97-106.
23. Phillips RF, Higinbotham NL. The curability of Ewing's endothelioma of bone in children. J Pediatr. 1967;70:391-397.
24. Hustu HO, Holton C, James D Jr, et al. Treatment of Ewing's sarcoma with concurrent radiotherapy and chemotherapy. J Pediatr. 1968;73:249-251.
25. Burgert EO, Nesbit ME, Garnsey LA, et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: Intergroup Study IESS-II. J Clin Oncol. 1990;8:1514-1524.
26. Craft AW, Cotterill S, Bullimore JA, et al. Long-term results from the first UKCCSG Ewing's tumour study (ET-1): United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer. 1997;33:1061-1069.
27. Jurgens H, Exner U, Gadner H, et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer. 1988;61:23-32.
28. Kolb EA, Kushner BH, Gorlick R, et al. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. J Clin Oncol. 2003;21:3423-3430.